# Terazosin

NDC: 59746-384
Generic name: Terazosin Hydrochloride
Labeler / Manufacturer: Jubilant Cadista Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20041220

FDA application: ANDA075317

## Active ingredients

- TERAZOSIN HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59746-384"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59746-384
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43e92495-2cf2-46dd-a80c-f0c3c88c7b73